Abstract
HIV-1 specific phenylacetamide derivatives: A novel class of reverse transcriptase inhibitors with potent and selective antiviral activity in vitro: R. Pauwels 1, K. Andries 2, Z. Debyser 1, P. Van Daele 2, D. Schols 1, M.A.C. Janssen 2, J. Desmyter 1, E. De Clercq 1 and P.A.J. Janssen 21Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium and
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
